secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDT CORP (IDT)
CIK:        0001005731
Form:       8-K
Filed at:   2026-06-11T21:03:26+00:00
Accession:  0001437749-26-020335
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDT Director Irwin Katsof resigns; William Conkling appointed to board
----------------------------------------------------------------------

- Irwin Katsof resigned from the board on June 9, 2026; no disagreement cited.
- Board appointed William Conkling as director, effective June 9, 2026.
- Conkling, 55, is CCO of Protara Therapeutics; former CEO of Rafael Holdings.
- He will chair Audit Committee and serve on Compensation and Governance committees.
- Conkling deemed independent under NYSE and SEC standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005731/000143774926020335/0001437749-26-020335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005731/000143774926020335/idt20260611_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-020335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer